CLL Society

As colder weather approaches and more time is spent indoors, the risk of respiratory infections like COVID-19, influenza, RSV, and bacterial pneumonia increases. Learn how you can protect yourself against infection at CLL Society's next webinar on December 13th at 9am PT / 12pm ET. Register and learn more at: https://bit.ly/3UXn4C2

Happy Thanksgiving! CLL Society wishes everyone a joyful holiday spent with loved ones.

In honor of #NationalFamilyCaregiversMonth, we recognize the invaluable role that care partners play in supporting loved ones living with CLL/SLL, helping them achieve the best quality life. But caring for a loved one can come with challenges and it's crucial for care partners to take care of their own health and wellbeing too. Watch our past educational event and learn about proven strategies and resources that can support care partners in caring for themselves while continuing to provide the best care for their loved ones: https://bit.ly/3qaMGfP

Richter’s transformation is a hard-to-treat complication of CLL. A stem cell transplant may be a beneficial treatment option for some patients. https://bit.ly/3V5Es7s

When Doreen was diagnosed with CLL/SLL (chronic lymphocytic leukemia/small lymphocytic lymphoma), she had never heard of this cancer before. In her search for trustworthy information, she found CLL Society, where she learned how to navigate her CLL with confidence. This Giving Tuesday, you can help individuals like Doreen access the education and support resources they need to thrive when you give to CLL Society. CLL Society's #GivingTuesday campaign is live! A generous supporter is matching gifts up to $25,000, so make your donation early: https://bit.ly/4fBNnFY

#GivingTuesday is coming up on December 3rd. A diagnosis of chronic lymphocytic #leukemia (#CLL) can be overwhelming. Becoming educated about this cancer and connecting with fellow individuals impacted by it can make all the difference. Join CLL Society this Giving Tuesday as we work to enhance the lives of all those impacted by CLL and SLL.

CLL Society and PVI, PeerView Institute for Medical Education are partnering on a #CLL event during #ASH2024 that will provide expert-led conversations, paired with practically-oriented case discussions, to provide attendees with guidance on addressing common clinical challenges in CLL. Throughout, the panelists will debate evidence supporting the personalized selection of first-line regimens; the experience with BTK-BCL2 inhibitor combinations; sequential therapy with non-covalent BTKi and CAR-T options; and the role of newer modalities in challenging pretreated and double-exposed populations. Don’t miss this event on 12/06 at 11:00 AM PST in person at ASH or virtually. https://bit.ly/L2024-CLL

Epcoritimab is being explored to treat individuals with relapsed or refractory CLL. https://bit.ly/4fU2JFr

In the third episode of CareCast, care partner Susan Bottega reflects on the emotional impacts she felt following her husband's diagnosis of chronic lymphocytic leukemia (CLL). She reflects on the importance of being informed about the disease as a care partner and the value CLL Society Support Groups have had in her life. Listen to CareCast: https://bit.ly/4cyQYSM. Also available on Spotify and Apple Podcast.

Join CLL Society for our next webinar, Common Infections with CLL: Prevention and Treatment on Friday, 12/13 at 9am PT / 12pm ET. We will be joined by Dr. William Werbel to discuss managing infection risks to help protect those who are immunocompromised. Register at: https://bit.ly/3UXn4C2